1. Home
  2. HCSG vs MESO Comparison

HCSG vs MESO Comparison

Compare HCSG & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCSG
  • MESO
  • Stock Information
  • Founded
  • HCSG 1976
  • MESO 2004
  • Country
  • HCSG United States
  • MESO Australia
  • Employees
  • HCSG N/A
  • MESO N/A
  • Industry
  • HCSG Assisted Living Services
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HCSG Health Care
  • MESO Health Care
  • Exchange
  • HCSG Nasdaq
  • MESO Nasdaq
  • Market Cap
  • HCSG 1.1B
  • MESO 1.3B
  • IPO Year
  • HCSG N/A
  • MESO N/A
  • Fundamental
  • Price
  • HCSG $12.72
  • MESO $15.73
  • Analyst Decision
  • HCSG Buy
  • MESO Buy
  • Analyst Count
  • HCSG 5
  • MESO 4
  • Target Price
  • HCSG $14.80
  • MESO $18.00
  • AVG Volume (30 Days)
  • HCSG 768.8K
  • MESO 311.7K
  • Earning Date
  • HCSG 07-23-2025
  • MESO 08-28-2025
  • Dividend Yield
  • HCSG N/A
  • MESO N/A
  • EPS Growth
  • HCSG N/A
  • MESO N/A
  • EPS
  • HCSG 0.55
  • MESO N/A
  • Revenue
  • HCSG $1,739,911,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • HCSG $7.54
  • MESO $178.09
  • Revenue Next Year
  • HCSG $4.55
  • MESO $305.06
  • P/E Ratio
  • HCSG $23.03
  • MESO N/A
  • Revenue Growth
  • HCSG 3.71
  • MESO N/A
  • 52 Week Low
  • HCSG $9.13
  • MESO $5.78
  • 52 Week High
  • HCSG $15.73
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • HCSG 30.67
  • MESO 75.38
  • Support Level
  • HCSG $12.95
  • MESO $10.96
  • Resistance Level
  • HCSG $13.25
  • MESO $11.32
  • Average True Range (ATR)
  • HCSG 0.53
  • MESO 0.41
  • MACD
  • HCSG -0.23
  • MESO 0.35
  • Stochastic Oscillator
  • HCSG 7.72
  • MESO 91.31

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: